OVERSEE-II
Identification of Potential Improvements in the Acute Care Pathway for Cancer Patients in the Emergency Department (OVERSEE - II Trial)
Sponsor study identifier
observational
59
1 country
1
Study Start
February 2, 2024
Actual (reported)Primary Completion
September 1, 2024
Actual (reported)Study Completion
October 1, 2024
Actual (reported)The goal of this Single center prospective cross-sectional study is to identify the facilitators and barriers among caregivers in the emergency department that influence disposition of patients with solid and hematology malignancies. The main question it aims to answer is to categorize the facilitators and barriers identified by three groups of emergency department (ED) staff. Participants will be asked for permission, afterwards a short interview will be held with the different ED caregivers (ED nurse, attending physician and supervising physician).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 1, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 18, 2023
Actual (reported)August 3, 2023
Actual (reported)February 2, 2024
Actual (reported)September 1, 2024
Actual (reported)October 1, 2024
Actual (reported)Clusters of facilitator and barriers identified by the emergency department (ED) nurse
(Sub)Clusters of facilitator and barriers identified by the ED nurse for the ED care of patients with cancer
Through study completion, an average of 6 months
Clusters of facilitator and barriers identified by the treating physician
(Sub)Clusters of facilitator and barriers identified by the treating physician for the ED care of patients with cancer
Through study completion, an average of 6 months
Clusters of facilitator and barriers identified by the supervising physician
(Sub)Clusters of facilitator and barriers identified by the supervising physician for the ED care of patients with cancer
Through study completion, an average of 6 months
Emergency department (ED) length of stay (LOS)
Through study completion, an average of 6 months
Disposition
Through study completion, an average of 6 months
Correlation between ED-LOS and disposition
Through study completion, an average of 6 months
Years of medical experience
Through study completion, an average of 6 months
Need for imaging
Through study completion, an average of 6 months
Patient characteristics
Through study completion, an average of 6 months
All adult patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months that are admitted to the emergency department of the Erasmus medical center for the oncology, hematological, lung- and neuro-oncology medical unit are eligible for inclusion.
The interview focuses on several parts of the emergency care process: The first part is regarding the actions that are executed during an emergency department visit. We will establish which actions are executed and why. The second part is regarding the suspected outcome for the patient. The third part will be about any potential improvements to the emergency care process for the patient.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
In the emergency department (ED) of Erasmus medical center (MC) yearly around 1600 patients with cancer are presented to the ED. Based on the study design we will conduct interviews with 75 to 100 patients with solid and hematologic malignancies, who are receiving systemic therapy or have received systemic therapy within the last 3 months and are admitted to the ED department of the Erasmus MC for the oncology, hematology, lung- and neuro-oncology medical unit. If present, the interview will also be held with the family caregiver.
Erasmus MC
Rotterdam, South Holland, 3015GD, Netherlands
Jason den Duijn
Erasmus Medical Center
59 participants (actual enrollment reported by the registry).
First Submitted
July 18, 2023
First Posted
August 3, 2023
Study Start
February 2, 2024
Actual (reported)Palliative Care Yields Cancer Wellbeing Support
Eating Experience at the Comprehensive Cancer Center Wards - a Qualitative Study
Contact the study team to confirm eligibility.
Primary Completion
September 1, 2024
Actual (reported)Study Completion
October 1, 2024
Actual (reported)Last Updated
October 15, 2024
Record last verified: 2024-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: